In this study, in addition to BEV, we used AFL or RAM as a VEGF inhibitor and patients treated with these types of VEGF inhibitors had experienced AEs, such as neutropenia, hypertension, and proteinuria more frequently than those treated with BEV. This evidence concerns the gene VEGFA and Hypertension.